Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$121B
sum of reported positions
Reported positions
698
Changes vs prior quarter
593
53 new · 44 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 254 measured positions in 8 quarters, the typical new or larger position finished −0.9 pts against the S&P 500 and 46% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $115B | $121B |
| Positions | 689 | 698 |
| Biggest line | — | NVIDIA 5% |
| 12.2M |
| $2.9B |
| 2.4% |
| 7.38M | $2.79B | 2.3% |
| 4.9M | $2.34B | 1.9% |
| 6.21M | $2.31B | 1.9% |
| 6.46M | $2.22B | 1.8% |
| 3.77M | $2.12B | 1.8% |
| 24.2M | $1.8B | 1.5% |
| 895K | $1.78B | 1.5% |
| 4.16M | $1.42B | 1.2% |
| 4.17M | $1.37B | 1.1% |
| 5.34M | $1.36B | 1.1% |
| 2.48M | $1.29B | 1.1% |
| 4.21M | $1.26B | 1.0% |
| 2.34M | $1.16B | 1.0% |
Exxon Mobil Corp | 8.48M | $1.16B | 1.0% |
| 16M | $1.14B | 0.9% |
| 2.65M | $1.13B | 0.9% |
| 754K | $1.03B | 0.8% |
| 6.01M | $1.02B | 0.8% |
| 5.02M | $952M | 0.8% |
| 2.81M | $928M | 0.8% |
| 4.66M | $885M | 0.7% |
Karman Holdings (KRMN)
515K → 1.46M shares (+183%)
Xometry (XMTR)
708K → 742K shares (+5%)
Brookfield Infrastructure (BIPC)
44K → 1.86M shares (+4117%)
Anheuser-Busch Inbev (BUD)
102K → 863K shares (+749%)
Churchill Downs Inc. (CHDN)
744K → 786K shares (+6%)
Valvoline (VVV)
1.46M → 1.76M shares (+21%)
Kinetik Holdings, Inc. (KNTK)
1.4M → 1.42M shares (+2%)
CF Industries (CF)
11K → 633K shares (+5874%)
Arch Capital Group (ACGL)
345K → 705K shares (+104%)
CBRE Group (CBRE)
489K → 499K shares (+2%)
State Street SPDR S&P Biotech ETF
417K → 424K shares (+2%)
Celsius Holdings (CELH)
2.01M → 2.28M shares (+14%)
Orix (IX)
1.05M → 1.75M shares (+67%)
Digital Realty (DLR)
240K → 364K shares (+52%)
Nu Holdings (NU)
4.41M → 4.86M shares (+10%)
Builders Firstsource (BLDR)
670K → 717K shares (+7%)
Ncino (NCNO)
2.11M → 3.91M shares (+85%)
Dutch Bros Inc. (BROS)
859K → 872K shares (+1%)
Telus (TU)
5.17M → 5.84M shares (+13%)
Prologis (PLD)
372K → 453K shares (+22%)
Legence (LGN)
402K → 719K shares (+79%)
Glaukos Corp. (GKOS)
286K → 431K shares (+51%)
Axsome Therapeutics (AXSM)
45K → 246K shares (+446%)
PJT Partners, Inc. (PJT)
377K → 394K shares (+5%)
Booking Holdings (BKNG)
11K → 332K shares (+2966%)